• BG IRIS Research Client Login
logo
  • Home
  • Services
    • Investment Banking
      • Our transactions
      • Private Placements
      • Public Offerings
      • M&A for private companies
      • M&A for public companies
    • Capital Markets
      • Institutional Sales
      • Derivatives Sales & Trading
    • Research
      • Equity Research
      • Corporate Research
      • Equity Research login
    • Sectors
      • Healthcare
      • Software
      • Energy Transition & Sustainability
      • Industrial Tech
      • NextGen Consumer
      • Business & Tech-enabled Services
  • Company news
  • BG IRIS
  • Events
  • About us
    • Senior Team
    • About us
    • Contact Us
  • Careers
    • Our vacancies
    • Our Investment Banking Positions
    • Current Equity Sales & Research Positions
    • Current Support Team Offerings
    • Current Internship Offerings
  • BG CLIENT FOCUS
  • Search
  • BG IRIS Research Client Login

Our transactions

Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.

  • All
  • Healthcare
  • Software & Fintech
  • Industrial Tech
  • Energy Transition & Sustainability
  • Business & Tech-enabled Services
  • NextGen Consumer
  • M&A
  • Private Placements
  • ECM

Bryan, Garnier & Co acted as sole financial advisor to Mailinblack and its shareholders on the LBO led by Apax Partners alongside New Alpha Verto, management and historical shareholders

Bryan, Garnier & Co acted as Sole Financial Advisor to New Alpha Verto on its investment in GAC Technology

Bryan, Garnier & Co acts as Sole Global Coordinator and Joint Bookrunner on Abivax’s EUR 49 million Cross-over Financing

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders, Altana AG and Hans Mathea, founder and CEO of dp polar GmbH, a leading developer and producer of 3D printing systems for industrial series production on the sale of the Company to NYSE-listed 3D Systems

Bryan, Garnier & Co acts as Sole Financial Advisor to Ganymed Robotics, a developer of computer vision software and robotics technologies for orthopedic surgeons, on its first €21 million closing of its oversubscribed Fundraising

Bryan, Garnier & Co acts as Sole Financial Advisor to Oncodesign on the sale of its CRO activities to Elyan Partners for €100m and the concomitant spin-off of its Biotech/AI activities

Deal Agile MV

Bryan, Garnier & Co acted as Sole Financial Advisor to Vade and its shareholders on its €28m fundraising from Tikehau Ace Capital, Bpifrance and Auriga Partners

Bryan, Garnier & Co acts as Sole Financial Advisor to the Management of Astrocast, leading global IoT satellite operator, on its contemplated acquisition of Hiber

Bryan, Garnier & Co acts as Sole Financial Advisor to Laurent Blanc and Phillimore, shareholders of the design and lifestyle media group Ideat Editions, on its contemplated sale to I/O Media

Bryan Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Lhyfe on its landmark €110m IPO on Euronext Paris

Bryan, Garnier & Co acts as Sole Financial Advisor to Enapter AG on a €20m strategic investment from Johnson Matthey

Bryan, Garnier & Co acts as Sole Financial Advisor to Bridgepoint Development Capital on their contemplated investment in CAST

Bryan, Garnier & Co acts as Sole Global Coordinator & Sole Bookrunner on GeNeuro EUR 7.7 million Follow-On Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to the Sellers of Våning 18 to Äleven

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Grundium Oy on the sale of a majority stake to EW Healthcare Partners

Bryan, Garnier & Co advises Qualium Investissement on its acquisition of Recocash from IK Partners

Bryan, Garnier & Co acts as Sole Financial Advisor to Capza and the Management of Horizon Software, leading electronic trading software provider, on the contemplated sale of the Company to Sagard NewGen

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Avantium’s Euronext Amsterdam EUR 45m Publicly Marketed Follow-On Offering

Deal Terranova Security

Bryan, Garnier & Co acts as Sole Financial Advisor to Protix on its €50 million Fundraising

Bryan, Garnier & Co advises Cathay Capital, Sagard NewGen and Eurazeo on their investment in DiliTrust

Bryan, Garnier & Co acts as Sole Financial Advisor and Sole Placement Agent to the leading geo-analytics company Kayrros on its €40 million Series C financing from New Space Capital, Bpifrance, Opera Tech Ventures (BNP Paribas VC arm), EIB and existing shareholders

Bryan, Garnier & Co acts as Sole Financial Advisor to Praxedo and its founders on a growth LBO led by MBO & Co

Bryan, Garnier & Co acts as Exclusive Financial Advisor to the shareholders and founders of kompany on the sale of the company to Moody’s

Bryan, Garnier & Co acts as Sole Financial Advisor to Sword Group SE on the disposal of Sword GRC to Riskonnect, a portfolio company of TA Associates

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Aelis Farma’s Euronext Paris EUR 25m Initial Public Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to clinical-stage biologics company BiosanaPharma on its global strategic partnership with Alvotech

Bryan, Garnier & Co acts as Sole Financial Advisor to Padoa and its shareholders on the investment of Five Arrows Growth Capital

Bryan, Garnier & Co acted as Sole Financial Advisor to the shareholders of CyberCité, a SEO and SEA agency, on the sale of the Company to Isoskele, part of Groupe La Poste

Bryan, Garnier & Co acts as Sole Financial Advisor to MNH on the sale of AKLIA to Hoppen

Bryan, Garnier & Co is proud to act as Joint Bookrunner to Cell Impact on its SEK 349m Rights Issue

Bryan, Garnier & Co acts as Sole Financial Advisor to Wandercraft on its $45 million Fundraising

Bryan, Garnier & Co acted as Sole Financial Advisor to the shareholders of CMN on its partnership with MBO & Co

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Headwall Photonics on the sale of the company to Arsenal Capital Partners

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Nicox on its EUR 15 million Follow-on Offering of shares and warrants

Bryan, Garnier & Co acts as Sole Financial Advisor to Aquiline Capital Partners and Elyan Partners on their potential investment in Cheops Technology

Deal Gnet Media

Bryan, Garnier & Co acts as Sole Financial Advisor to the sellers of Human Performance to Äleven

Bryan, Garnier & Co acts as Lead Joint Bookrunner to leading German Specialty Pharmaceuticals provider Medios AG on its EUR 93 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor, Sole Global Coordinator and Sole Bookrunner to leading global IoT satellite operator Astrocast on its private placement and subsequent direct listing on Euronext Growth, securing a total of CHF 45 million for the company

Bryan, Garnier & Co acts as Sole Financial Advisor to Quilvest Capital Partners and the Management of Eudonet, a European vertical CRM software provider, on the sale of the Company to Montagu Private Equity

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders and founders of Evora IT Solutions Group on the sale of the company to Allgeier SE

Calcium Deal

Bryan, Garnier & Co acts as Sole Financial Advisor to EasyVista on its acquisition of ServiceNav by Coservit

Bryan, Garnier & Co acts as Sole Global Coordinator and Joint Bookrunner on Enapter Follow-On Offering of EUR 30m

Bryan, Garnier & Co acts as Joint Bookrunner on Valneva’s Nasdaq & Euronext Paris USD 102m Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to XVIVO on its acquisition of STAR Teams, and as Joint Global Coordinator on subsequent SEK 250 million Follow-on Offering

Bryan, Garnier & Co is proud to act as Sole Financial Advisor, Sole Global Coordinator & Joint Bookrunner to Waga Energy on its EUR 126m Initial Public Offering including Strategic Investments from Vitol, CMA CGM and Viva Energy

Bryan, Garnier & Co acts as Sole Advisor and Sole Global Coordinator on Claranova’s EUR 65 million PIPE

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Elmatica in the sale of the company to NCAB Group AB

Bryan, Garnier & Co acts as Sole Financial Advisor to Cleerly on its USD 43 million Series B Fundraising

  • 1
  • 2
  • 3
  • 4
  • …
  • 11
Menu

Home

All transactions

Investment Banking

Capital Markets

Sectors

Our Insights

Other

Events

Senior Team

Careers

About us

Press

Contact us

Legal

  • Legal Information
  • Index 2022
  • Bryan Garnier Securities
  • Privacy Policy

Latest News

  • Venture Capital Forum 2023 with Invest Europe
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
SAVE & ACCEPT

Privacy Preference Center

Privacy Preferences

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }